The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/30601
StudyName: Eligibility Metastatic Breast Cancer NCT00943670
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 17.06.2018
License: Creative Commons BY 4.0

----

Description: 
Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression; ODM derived from: https://clinicaltrials.gov/show/NCT00943670
